Greenup Street Wealth Management LLC Purchases 168 Shares of Zoetis Inc. (NYSE:ZTS)

Greenup Street Wealth Management LLC lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 2.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 8,243 shares of the company’s stock after purchasing an additional 168 shares during the quarter. Greenup Street Wealth Management LLC’s holdings in Zoetis were worth $1,343,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ZTS. Darwin Wealth Management LLC acquired a new position in shares of Zoetis in the 3rd quarter valued at about $31,000. First Personal Financial Services bought a new position in shares of Zoetis during the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Zoetis during the 3rd quarter worth approximately $33,000. Dunhill Financial LLC increased its stake in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares in the last quarter. Finally, Quarry LP lifted its position in shares of Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after acquiring an additional 153 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ZTS. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. JPMorgan Chase & Co. upped their price target on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus lowered their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Leerink Partners initiated coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. Finally, UBS Group initiated coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price target for the company. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Up 2.6 %

Zoetis stock opened at $173.07 on Tuesday. The firm’s 50-day simple moving average is $170.10 and its 200 day simple moving average is $179.75. The stock has a market cap of $78.08 billion, a PE ratio of 32.53, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.53. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same period in the prior year, the firm earned $1.36 EPS. The company’s revenue was up 11.6% compared to the same quarter last year. Research analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is Tuesday, January 21st. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.